Karabulut, M. Et Al. 2017. SERUM INTERLEUKIN-32 (IL-32) LEVELS MAY HAVE DIAGNOSTIC AND PROGNOSTIC ROLES IN PATIENTS WITH PANCREATIC ADENOCARCINOMA. ACTA MEDICA MEDITERRANEA , no.4 , 613-619.

Karabulut, M., Afsar, C. U., Karabulut, S., Peker, K. D., Gemici, E., Dagoglu, N., ... Karaman, S.(2017). SERUM INTERLEUKIN-32 (IL-32) LEVELS MAY HAVE DIAGNOSTIC AND PROGNOSTIC ROLES IN PATIENTS WITH PANCREATIC ADENOCARCINOMA. ACTA MEDICA MEDITERRANEA , no.4, 613-619.

Karabulut, Mehmet Et Al. "SERUM INTERLEUKIN-32 (IL-32) LEVELS MAY HAVE DIAGNOSTIC AND PROGNOSTIC ROLES IN PATIENTS WITH PANCREATIC ADENOCARCINOMA," ACTA MEDICA MEDITERRANEA , no.4, 613-619, 2017

Karabulut, Mehmet Et Al. "SERUM INTERLEUKIN-32 (IL-32) LEVELS MAY HAVE DIAGNOSTIC AND PROGNOSTIC ROLES IN PATIENTS WITH PANCREATIC ADENOCARCINOMA." ACTA MEDICA MEDITERRANEA , no.4, pp.613-619, 2017

Karabulut, M. Et Al. (2017) . "SERUM INTERLEUKIN-32 (IL-32) LEVELS MAY HAVE DIAGNOSTIC AND PROGNOSTIC ROLES IN PATIENTS WITH PANCREATIC ADENOCARCINOMA." ACTA MEDICA MEDITERRANEA , no.4, pp.613-619.

@article{article, author={Mehmet Karabulut Et Al. }, title={SERUM INTERLEUKIN-32 (IL-32) LEVELS MAY HAVE DIAGNOSTIC AND PROGNOSTIC ROLES IN PATIENTS WITH PANCREATIC ADENOCARCINOMA}, journal={ACTA MEDICA MEDITERRANEA}, year=2017, pages={613-619} }